CLINICAL_TRIALS
trial_result
· 2018-10-24
Clinical Trial Update: Apremilast in Palmo-Plantar Psoriasis [Phase 4]
Summary
Phase 4 trial of apremilast for palmo-plantar psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovaderm Research Inc. | Conditions: Palmo-plantar Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2018-10-24